Edwin J. Heeregrave

406 total citations
7 papers, 315 citations indexed

About

Edwin J. Heeregrave is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Edwin J. Heeregrave has authored 7 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in Edwin J. Heeregrave's work include HIV Research and Treatment (5 papers), Hepatitis C virus research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Edwin J. Heeregrave is often cited by papers focused on HIV Research and Treatment (5 papers), Hepatitis C virus research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Edwin J. Heeregrave collaborates with scholars based in Netherlands, United States and United Kingdom. Edwin J. Heeregrave's co-authors include Georgios Pollakis, William A. Paxton, Tom Cupedo, Mark F. R. Vondenhoff, Reina E. Mebius, David G. Jackson, David R. Ambrozak, Georg Kraal, Richard A. Koup and Wendy Jansen and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Edwin J. Heeregrave

7 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin J. Heeregrave Netherlands 4 184 137 132 110 53 7 315
Bonnie Phillips United States 7 182 1.0× 202 1.5× 109 0.8× 59 0.5× 22 0.4× 7 314
Yuria Ablanedo‐Terrazas Mexico 10 134 0.7× 84 0.6× 138 1.0× 134 1.2× 32 0.6× 23 340
Antoni Tarrats Spain 10 110 0.6× 48 0.4× 121 0.9× 80 0.7× 63 1.2× 15 271
Wenzhen Kang China 11 112 0.6× 128 0.9× 119 0.9× 115 1.0× 24 0.5× 22 341
Yunden Badralmaa United States 6 72 0.4× 103 0.8× 59 0.4× 136 1.2× 35 0.7× 11 293
Shu-Ying Liu China 5 177 1.0× 47 0.3× 72 0.5× 148 1.3× 29 0.5× 9 305
Antigoni Morou Canada 7 215 1.2× 125 0.9× 73 0.6× 90 0.8× 17 0.3× 8 348
Anbalagan Selvaraj India 9 82 0.4× 135 1.0× 146 1.1× 47 0.4× 134 2.5× 14 300
Bindu Raju United States 9 118 0.6× 212 1.5× 176 1.3× 57 0.5× 69 1.3× 10 334
Susanna Ip Australia 8 286 1.6× 108 0.8× 157 1.2× 193 1.8× 76 1.4× 8 467

Countries citing papers authored by Edwin J. Heeregrave

Since Specialization
Citations

This map shows the geographic impact of Edwin J. Heeregrave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin J. Heeregrave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin J. Heeregrave more than expected).

Fields of papers citing papers by Edwin J. Heeregrave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin J. Heeregrave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin J. Heeregrave. The network helps show where Edwin J. Heeregrave may publish in the future.

Co-authorship network of co-authors of Edwin J. Heeregrave

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin J. Heeregrave. A scholar is included among the top collaborators of Edwin J. Heeregrave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin J. Heeregrave. Edwin J. Heeregrave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Heeregrave, Edwin J., et al.. (2023). Glycan dependent phenotype differences of HIV-1 generated from macrophage versus CD4+ T helper cell populations. Frontiers in Immunology. 14. 1107349–1107349. 2 indexed citations
2.
Seben, Rosanne van, et al.. (2022). Shared decision making for women with uncomplicated Cystitis in Primary Care in the Netherlands: a qualitative interview study. BMC Primary Care. 23(1). 259–259. 3 indexed citations
3.
Geldmacher, Christof, Njabulo Ngwenyama, Alexandra Schuetz, et al.. (2010). Preferential infection and depletion of Mycobacterium tuberculosis –specific CD4 T cells after HIV-1 infection. The Journal of Experimental Medicine. 207(13). 2869–2881. 179 indexed citations
4.
Cornelissen, Marion, Edwin J. Heeregrave, Fokla Zorgdrager, et al.. (2010). Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads. Archives of Virology. 155(12). 2017–2022. 4 indexed citations
5.
Heeregrave, Edwin J., et al.. (2010). Varied sensitivity to therapy of HIV-1 strains in CD4+ lymphocyte sub-populations upon ART initiation. AIDS Research and Therapy. 7(1). 3 indexed citations
6.
Heeregrave, Edwin J., Jason M. Brenchley, Elly Baan, et al.. (2009). Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets. Virology. 393(1). 24–32. 26 indexed citations
7.
Cupedo, Tom, Mark F. R. Vondenhoff, Edwin J. Heeregrave, et al.. (2004). Presumptive Lymph Node Organizers are Differentially Represented in Developing Mesenteric and Peripheral Nodes. The Journal of Immunology. 173(5). 2968–2975. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026